EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.3.48 | gene Ptpn22, real-time PCR expression analysis | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.1.3.48 | R619W | naturally occuring polymorphisms, phenotype, overview. Ptpn22-/- mice and Ptpn22R619W mutant mice are backcrossed for more than 10 generations to the C57BL/6 strain, genotyping and phenotyping in bone marrow derived dendritic cell culture, overview | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.3.48 | [a protein]-tyrosine phosphate + H2O | Mus musculus | - |
[a protein]-tyrosine + phosphate | - |
? | |
3.1.3.48 | [a protein]-tyrosine phosphate + H2O | Mus musculus C57BL/6 | - |
[a protein]-tyrosine + phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.3.48 | Mus musculus | E9QAS3 | - |
- |
3.1.3.48 | Mus musculus C57BL/6 | E9QAS3 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.3.48 | bone marrow-derived dendritic cell | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.3.48 | [a protein]-tyrosine phosphate + H2O | - |
Mus musculus | [a protein]-tyrosine + phosphate | - |
? | |
3.1.3.48 | [a protein]-tyrosine phosphate + H2O | - |
Mus musculus C57BL/6 | [a protein]-tyrosine + phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.3.48 | protein tyrosine phosphatase | - |
Mus musculus |
3.1.3.48 | PTPN22 | - |
Mus musculus |
3.1.3.48 | tyrosine-protein phosphatase non-receptor type 22 | UniProt | Mus musculus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.1.3.48 | malfunction | the C1858T polymorphism within the protein tyrosine phosphatase PTPN22 (encoding PTPN22R619W) is a major risk factor for the development of multiple autoimmune diseases, including rheumatoid arthritis (RA), type I diabetes, lupus and juvenile idiopathic arthritis (JIA). The autoimmune associated PTPN22R619W variant displays reduced binding to the tyrosine kinase Csk, due to a missense mutation in the P1 domain. Ptpn22 variants do not alter BMDC receptor mediated phagocytosis | Mus musculus |
3.1.3.48 | physiological function | Ptpn22 in the mouse negatively regulates Src and Syk family kinase (SFK) activity downstream of the T-cell antigen receptor (TCR). In addition to TCR signalling, PTPN22 regulates many pathways in different cell types including the B-cell receptor, the alphaLbeta2 integrin LFA-1 and Toll-Like Receptor (TLR) signalling pathways. Ptpn22 also functions to alter SFK independent signalling events by modulating TRAF ubiquitination. Macropinocytosis does not require Ptpn22. Splenic dendritic cell uptake of ovalbumin occurs independently of Ptpn22. Ptpn22 is dispensable for antigen processing and presentation and is redundant for dendritic cell activation of antigen specific T-cells. Ptpn22 variants do not modulate BMDC dependent OT-II T-cell activation | Mus musculus |